Want to see TSE:DTC full AI Analyst Report?

Defence Therapeutics (DTC) Revenue

14 Followers

Defence Therapeutics Revenue

Defence Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Sep 30, 2025, Defence Therapeutics had annual revenue of 0.00 with ― growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

C$0

Employees

Market Cap

C$30.32M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Sep 30, 2025	―	―	―
Jun 30, 2024	―	―	―
Sep 30, 2023	―	―	―
Sep 30, 2022	―	―	―
Sep 30, 2021	―	―	―
Jun 30, 2020	―	―	―
Jun 30, 2019	―	―	―